Suzhou Thery’s Generic Nilotinib Approved by China’s NMPA
China-based Suzhou Thery Pharmaceutical Inc. has announced that the National Medical Products Administration (NMPA) has...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity